The Journal of Allergy and Clinical Immunology
Volume 117, Issue 6 , Pages 1285-1291 , June 2006

Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell

Received 27 February 2006 ,Revised 4 April 2006 ,Accepted 5 April 2006.

References 

  1. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol. 2003;111:24–32
  2. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature. 2002;420:875–878
  3. Kitamura Y, Shimada M, Hatanaka K, Miyano Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature. 1977;268:442–443
  4. Crapper RM, Schrader JW. Frequency of mast cell precursors in normal tissues determined by an in vitro assay: antigen induces parallel increases in the frequency of P cell precursors and mast cells. J Immunol. 1983;131:923–928
  5. Ehrlich P. Uber die specifischen granulationen des Blutes. [abstract] Arch Anat Physiol Lpz. 1879;3:571–579
  6. Enerback L. Mast cells in rat gastrointestinal mucosa. 1. Effects of fixation. Acta Pathol Microbiol Scand. 1966;66:289–302
  7. Enerback L. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand. 1966;66:303–312
  8. Boyce J, Austen KF. Biology of the mast cell. In:  Austen KF,  Frank MM,  Atkinson JP,  Cantor H editor. Samter's immunologic diseases. Philadelphia: Lippincott, Williams, & Wilkins; 2001;p. 253–269
  9. Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J Cell Biol. 1996;135:279–290
  10. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis. 1993;147:697–704
  11. Robinson DS, Hamid Q, Jacobson M, Ying S, Kay AB, Durham SR. Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol. 1993;15:17–27
  12. Ruitenberg EJ, Elgersma A. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature. 1976;264:258–260
  13. Irani AM, Craig SS, DeBlois G, Elson CO, Schechter NM, Schwartz LB. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol. 1987;138:4381–4386
  14. Madden KB, Urban JF, Ziltener HJ, et al. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol. 1991;147:1387–1391
  15. Sonoda S, Sonoda T, Nakano T, Kanayama Y, Kanakura Y, Asai H, et al. Development of mucosal mast cells after injection of a single connective tissue-type mast cell in the stomach mucosa of genetically mast cell-deficient W/Wv mice. J Immunol. 1986;137:1319–1322
  16. Arinobu Y, Iwasaki H, Gurish MF, Mizuno S, Shigematsu H, Ozawa H, et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci U S A. 2005;102:18105–18110
  17. Guy-Grand D, Dy M, Luffau G, Vassalli P. Gut mucosal mast cells. Origin, traffic, and differentiation. J Exp Med. 1984;160:12–28
  18. Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science. 1996;271:818–822
  19. Yuan Q, Gurish MF, Friend DS, Austen KF, Boyce JA. Generation of a novel stem cell factor-dependent mast cell progenitor. J Immunol. 1998;161:5143–5146
  20. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood. 1999;94:2333–2342
  21. Rottem M, Goff JP, Albert JP, Metcalfe DD. The effects of stem cell factor on the ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures. J Immunol. 1993;151:4950–4963
  22. Jamur MC, Grodzki AC, Berenstein EH, Hamawy MM, Siraganian RP, Oliver C. Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood. 2005;105:4282–4289
  23. Pennock JL, Grencis RK. In vivo exit of c-kit+/CD49dhi/{beta}7+ mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis. Blood. 2004;103:2655–2660
  24. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A. 2005;102:11408–11413
  25. Gurish MF, Tao H, Abonia JP, Arya A, Friend DS, Parker CM, et al. Intestinal mast cell progenitors require CD49dβ7 (α4β7 integrin) for tissue-specific homing. J Exp Med. 2001;194:1243–1252
  26. Artis D, Humphreys NE, Potten CS, Wagner N, Muller W, McDermott JR, et al. Beta7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection. Eur J Immunol. 2000;30:1656–1664
  27. Kitamura Y, Yokoyama M, Sonoda T, Mori KJ. Different radiosensitivities of mast-cell precursors in the bone marrow and skin of mice. Radiat Res. 1983;93:147–156
  28. Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, et al. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood. 2005;105:4308–4313
  29. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med. 1999;190:267–280
  30. Chandrasekar B, Melby PC, Sarau HM, Raveendran M, Perla RP, Marelli-Berg FM, et al. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem. 2003;278:4675–4686
  31. Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, Takayama T, et al. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat Immunol. 2002;3:295–304
  32. Lu-Kuo JM, Fruman DA, Joyal DM, Cantley LC, Katz HR. Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products. J Biol Chem. 2000;275:6022–6029
  33. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002;19:879–885
  34. Mwamtemi HH, Koike K, Kinoshita T, Ito S, Ishida S, Nakazawa Y, et al. An increase in circulating mast cell colony-forming cells in asthma. J Immunol. 2001;166:4672–4677
  35. Ikeda RK, Miller M, Nayar J, Walker L, Cho JY, McElwain S, et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol. 2003;171:4860–4867
  36. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699–1705
  37. Weller CL, Collington SJ, Brown JK, Miller HR, Al-Kashi A, Clark P, et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med. 2005;201:1961–1971

 Supported by grants HL 036110, AI 031599, AI 48802, and AI 052353 from the National Institutes of Health.Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(06)00867-0

doi: 10.1016/j.jaci.2006.04.017

The Journal of Allergy and Clinical Immunology
Volume 117, Issue 6 , Pages 1285-1291 , June 2006

Article Tools

* Image Usage & Resolution